Washington State
House of Representatives
Office of Program Research
BILL
ANALYSIS

Finance Committee

HB 3086

Brief Description: Creating a business and occupation tax exemption for chemotherapy and anticancer drugs dispensed pursuant to prescription.

Sponsors: Representatives Hunter, Orcutt, Cody, Schual-Berke, Clements, Appleton, Hinkle, Morrell, Fromhold, Curtis, McCoy, Haler, Woods, Dickerson, Chase, Conway, Kessler, Hudgins, Sells, Dunn, Green, Lantz, Ericks and McDonald.

Brief Summary of Bill
  • Provides a Business and Occupation tax exemption for sales of chemotherapy and anticancer drugs for infusion or injection for human use.

Hearing Date: 1/31/06

Staff: Bob Longman (786-7139).

Background:

Washington's major business tax is the business and occupation (B&O) tax. The B&O tax is imposed on the gross receipts of business activities conducted within the state, without any deduction for the costs of doing business. The tax is imposed on the gross receipts from all business activities conducted within the state. Revenues are deposited in the State General Fund. A business may have more than one B&O tax rate, depending on the types of activities conducted. There are a number of different B&O tax rates. The main rates are 0.471 percent for retailing; 0.484 percent for manufacturing, wholesaling, and extracting; and 1.5 percent for professional and personal services.

Public hospitals, nonprofit hospitals, and nonprofit community health centers are exempt from B&O tax on amounts received as compensation for health care services covered under the federal Medicare program, as well as from the Basic Health Plan and other medical assistance programs funded by the state of Washington. Amounts billed for these programs by other clinics or physicians are not exempt from tax.

Summary of Bill:

An exemption from B&O tax is provided for amounts derived from sales of prescription chemotherapy and anticancer drugs for infusion or injection for human use, if the drugs are sold for an amount not exceeding the rate at or below which the federal government reimburses under Medicare.

Appropriation: None.

Fiscal Note: Requested on January 19, 2006.

Effective Date: The bill takes effect 90 days after adjournment of session in which bill is passed.